Evidence map›Paper›PMID 31510101›Full record

ArticleMicroorganisms2019

Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.

Petra Prochazkova, Radka Roubalova, Jiri Dvorak, Helena Tlaskalova-Hogenova, Martina Cermakova, Petra Tomasova, Blanka Sediva, Marek Kuzma, Josef Bulant, Martin Bilej and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. A systematic review on the role of microbiota in the pathogenesis and treatment of eating disorders.European psychiatry : the journal of the Association of European Psychiatrists · 2020
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Eating disorders: are gut microbiota to blame?Trends in molecular medicine · 2024
    Article
  18. Gut Microbiome Changes in Anorexia Nervosa: A Comprehensive Review.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Petra ProchazkovaLaboratory of Cellular and Molecular Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. kohler@biomed.cas.cz.
Radka RoubalovaLaboratory of Cellular and Molecular Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. r.roubalova@biomed.cas.cz.
Jiri DvorakLaboratory of Cellular and Molecular Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. dvorak@biomed.cas.cz.
Helena Tlaskalova-HogenovaLaboratory of Cellular and Molecular Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. tlaskalo@biomed.cas.cz.
Martina CermakovaLaboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. martina.buganova@biomed.cas.cz.
Petra TomasovaLaboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. petra.tomasova@biomed.cas.cz.
Blanka SedivaLaboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. sediva@kma.zcu.cz.
Marek KuzmaLaboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. kuzma@biomed.cas.cz.
Josef BulantDepartment of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, Prague 2, Czech Republic. josef.bulant@gmail.com.
Martin BilejLaboratory of Cellular and Molecular Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., 1083 Videnska, Prague 4, Czech Republic. mbilej@biomed.cas.cz.
Pavel HrabakDepartment of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, Prague 2, Czech Republic. Pavel.Hrabak@vfn.cz.
Eva MeisnerovaDepartment of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, Prague 2, Czech Republic. Eva.Meisnerova@vfn.cz.
Alena LambertovaDepartment of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, Prague 2, Czech Republic. Alena.Lambertova@vfn.cz.
Hana PapezovaDepartment of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, Prague 2, Czech Republic. Hana.Papezova@vfn.cz.
Czech Academy of Sciences · CZCharles University · CZ

Funding

MINISTRY OF HEALTH OF THE CZECH REPUBLIC 17-28905A
6 · The paper itself

Abstract

The change in the gut microbiome and microbial metabolites in a patient suffering from severe and enduring anorexia nervosa (AN) and diagnosed with small intestinal bacterial overgrowth syndrome (SIBO) was investigated. Microbial gut dysbiosis is associated with both AN and SIBO, and therefore gut microbiome changes by serial fecal microbiota transplantation (FMT) is a possible therapeutic modality. This study assessed the effects of FMT on gut barrier function, microbiota composition, and the levels of bacterial metabolic products. The patient treatment with FMT led to the improvement of gut barrier function, which was altered prior to FMT. Very low bacterial alpha diversity, a lack of beneficial bacteria, together with a great abundance of fungal species were observed in the patient stool sample before FMT. After FMT, both bacterial species richness and gut microbiome evenness increased in the patient, while the fungal alpha diversity decreased. The total short-chain fatty acids (SCFAs) levels (molecules presenting an important source of energy for epithelial gut cells) gradually increased after FMT. Contrarily, one of the most abundant intestinal neurotransmitters, serotonin, tended to decrease throughout the observation period. Overall, gut microbial dysbiosis improvement after FMT was considered. However, there were no signs of patient clinical improvement. The need for an in-depth analysis of the donor´s stool and correct selection pre-FMT is evident.

Indexed as

Akkermansiafecal microbiota transplantation (FMT)Firmicutes/Bacteroidesmicrobial metabolitesmicrobiomeshort-chain fatty acidssmall intestinal bacterial overgrowth syndrome

Identifiers

PMID31510101
PMCPMC6780752
OpenAlexW2973142894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.